Inhibitors of cannabinoid receptors and glucose metabolism.


PURPOSE OF REVIEW Abdominal obesity is closely related to type 2 diabetes and overactivity of the endocannabinoid system. The present review aims at evaluating the role of endocannabinoid system in glucose dysregulation and the effects of cannabinoid 1 receptor blockade on glucose metabolism in both animal models and overweight/obese humans, especially with… (More)
DOI: 10.1097/MCO.0b013e3282fcea11


2 Figures and Tables

Cite this paper

@article{Scheen2008InhibitorsOC, title={Inhibitors of cannabinoid receptors and glucose metabolism.}, author={Andr{\'e} Scheen and Nicolas Paquot}, journal={Current opinion in clinical nutrition and metabolic care}, year={2008}, volume={11 4}, pages={505-11} }